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Abstract
Background: Neutrophils (PMN) are the first cells to infiltrate the lung after infection, and they play a significant
protective role in the elimination of pathogen, by releasing preformed oxidants and proteolytic enzymes from
granules and generating ROS, thus limiting inflammation by succumbing to apoptosis. In a previous study, we
found marked differences in ROS-induced apoptosis between two Mycobacterium tuberculosis (Mtb) strains, M and
Ra, representative of widespread Mtb families in South America, i.e. Haarlem and Latin-American Mediterranean
(LAM), being strain M able to generate further drug resistance and to disseminate aggressively.
Methods: In this study we evaluate the nature of bacteria-PMN interaction by assessing ROS production, apoptosis,
lipid raft coalescence, and phagocytosis induced by Mtb strains.
Results: Dectin-1 and TLR2 participate in Mtb-induced ROS generation and apoptosis in PMN involving p38 MAPK
and Syk activation with the participation of a TLR2-dependent coalescence of lipid rafts. Further, ROS production
occurs during the phagocytosis of non-opsonized bacteria and involves α-glucans on the capsule. In contrast, strain
M lacks the ability to induce ROS because of: 1) a reduced phagocytosis and 2) a failure in coalescence of lipid raft.
Conclusions: The differences in wall composition could explain the success of some strains which stay unnoticed
by the host through inhibition of apoptosis and ROS but making possible its replication inside PMN as a potential
evasion mechanism. Innate immune responses elicited by Mtb strain-to-strain variations need to be considered in
TB vaccine development.
Background
Tuberculosis (TB) remains a major global health problem
caused by inhalation of aerosols containing Mycobacter-
ium tuberculosis (Mtb). Ten million new TB cases and 2
million deaths are estimated to occur each year, more than
any time in history [1]. The risk of disease is also increased
by emergence of acquired immune deficiency syndrome
and multidrug-resistant (MDR) Mtb strains [1]. Whether
bacterial lineage influences on the development of TB dis-
ease is uncertain, although there is long-standing evidence
that some Mtb strains are more virulent than others and
vary in their ability to cause disease in humans [2].
Mtb has evolved successful strategies to invade and
persist within host cells and these interactions appear to
involve surface polysaccharides and glycolipids present in
the Mtb surface [3,4]. The capsule is the outermost com-
partment of the bacteria envelope [5,6] and is composed
of carbohydrates and proteins with only small amounts of
species- or type-specific lipids [7,8]. Mtb capsular carbohy-
drates are absent in some other taxa and mediate specific
interactions with the host [9]. The major carbohydrate
constituents from Mtb surface are α-glucans, which repre-
sent up to 80% of the extracellular polysaccharides. These
α-glucans are composed of a 4-α-DGlc-1 core branched at
position 6 every five or six residues by 4-α-D-Glc-1 oligo-
glucosides [7,8,10].
Recognition of mycobacterial components by Toll-like
receptors (TLRs) [11] is a key step in initiating innate
immune responses upon mycobacterial infection. In this
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context, it has been demonstrated that TLR2 stimulation
enhances production of reactive oxygen species (ROS)
that is accompanied by sustained phosphorylation of p38
mitogen-activated protein kinase (p38 MAPK), suggest-
ing an essential role of ROS in TLR2 signaling pathways
[12]. Moreover, several C-type lectin receptors also partici-
pate in the recognition of mycobacteria. Among them,
dectin-1 is a phagocytic receptor for fungal wall-derived
β-glucans that is expressed on monocytes (Mo), macro-
phages (MØ), neutrophils (PMN), dendritic cells (DC)
and Langerhans cells [13]. Dectin-1 was described to in-
duce ROS production in MØ [14] involving the spleen
tyrosine kinase (Syk) activation [15]. The role of dectin-1
in mycobacterial infections has begun to be studied re-
cently, and its role in the functionality of PMN has not
been investigated so far.
The most successful Mtb genotypes in South America
belong to three Euro-American families, i.e., Latin-
American Mediterranean (LAM), ill-defined T, and
Haarlem [16]. In Argentina, the only South America
country where large MDR-TB epidemics have been
documented [17], there are two main mycobacterial
clusters, strain M belonging to the Haarlem family, and
strain Ra belonging to LAM family [18]. In particular,
strain M disseminated aggressively building up further
drug resistance without impairing its ability to spread
and persist in the community.
Although MØ are the major target of Mtb infection,
how the innate immunity mediates host defense against
mycobacteria has long remained poorly understood. One
of the first events in the pathogenesis of the disease is
the influx of PMN to the lung. Being the most com-
monly infected phagocytes in human TB [19], PMN play
a significant protective role in the elimination of invad-
ing pathogens through the generation of ROS [20] and
the release of preformed oxidants and proteolytic enzymes
from granules [21], thereby contributing to the control of
Mtb infection [22]. In addition, PMN apoptosis can be
triggered with non-opsonized Mtb [23] involving TLR2
and p38 pathway [24,25] and oxidative processes, which
have been implicated in mycobacterial pathogenesis
[26]. The strict dependence of Mtb-induced apoptosis
on ROS production [23] suggests an important host
defense mechanism for removal of the infected PMN
from the site of infection which, in turn, can limit in-
flammation [27].
In a previous paper we showed that clinical strains
from LAM and Haarlem families differ in their ability to
induce ROS and apoptosis in PMN, a mechanism that
would allow immune evasion and survival of both bacteria
and PMN [28]. Herein, we investigated the mechanisms
that govern Mtb-induced ROS production in PMN and




All procedures were performed in compliance with institu-
tional guidelines and the relevant institutional committee
(Ethics Committee of the National Academy of Medicine
in Buenos Aires) approved our research. All healthy volun-
teers signed a written informed consent.
Mtb clinical isolates
Mtb clinical isolates were obtained from sputum culture
positive patients. The isolates had been previously sub-
mitted to drug susceptibility testing and genotyping by
IS6110 DNA fingerprinting and spoligotyping using
standardized protocols [18]. Two multidrug-resistant
strains (MDR) were employed in this study: Ra 11608
and M 6548 belonging to LAM and Haarlem families
respectively [28]. The isolates belonged to the collection
kept at the Reference Laboratory for Mycobacteria,
Instituto Nacional de Enfermedades Infecciosas ANLIS
“Carlos G. Malbran” in Buenos Aires, Argentina. All
strains were grown in Middlebrook 7H9 broth (Difco
Laboratories, Detroit MI, USA) at 37°C in 5% CO2 until
log phase. Mycobacteria were harvested, washed three
times and suspended in phosphate buffered saline (PBS)
free of pyrogen. Bacteria were killed by gamma irradi-
ation (2.4 megaRads) and suspended in PBS at an OD600
nm of 1 (~108 bacteria/ml) and stored at −20°C until
their use. When indicated, bacteria were heat killed at
121°C for 30 min. (ht Mtb).
Antibodies and reagents
Oxidase inhibitor, diphenyleneiodonium (DPI) was pro-
vided by Cayman Chemical (Michigan, USA), the specific
inhibitor of p38 (SB203580) and the Syk inhibitor Picea-
tannol (Pic) were purchased from Calbiochem-Behring
(La Jolla, CA, USA). The FITC-conjugated B subunit of
cholerae toxin (CTB), Annexin V-FITC, the lipid raft in-
hibitor β-Metil-ciclodextrin (MβC), the β-glucan Lami-
narin, PMA, Pam3Cys, cytochalasin D, orthovanadate and
amyloglucosidase (A3514, EC 3.2.1.3) were purchased
from (Sigma Chemical Co., St. Louis, Mo, USA) and dihy-
drorhodamine 123 (DHR) was purchased from Invitrogen.
Mouse antibodies (Abs) against phospho-(Thr180/
Tyr182)-p38 were purchased from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA, USA). Rabbit antihuman p-(Tyr525/
526)-Syk was purchased by Cell Signaling Technology
(Cell Signaling Technology, Inc., Danvers, MA), donkey
anti-mouse-IgG-FITC, Mouse antihuman-TLR2-FITC
(clone TL2.1) and blocking antibodies against human
CD11b and TLR2 (clone TL2.1) were purchased by Bio-
legend (Biolegend, San Diego, CA). Mouse antihuman-
dectin-1-PE (2A11) and mouse antihuman-dectin-1 (clone
259931) were purchased by R&D (R&D Systems inc.
Minneapolis USA) as well as their corresponding isotype.
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Amyloglucosidase digestion of the α-glucan on Mtb
capsule
Clinical strains Ra and M were treated with the enzyme
α-amyloglucosidase (Sigma Chemical Co.). To remove α-
glucans from the capsule, bacteria were centrifuged at
100 g and suspended in 1 ml of α-amyloglucosidase (500
U/ml) prepared in sodium acetate buffer 0.05 M and 0.1 M
NaCl, pH 4.5. As a control, the bacteria were also sus-
pended in enzyme-free buffer. Bacteria suspensions were
incubated at 37°C for 18 hr and then centrifuged at 100 g.
The supernatants were discarded, and the pellets were
washed with PBS. Thereafter, treated bacteria (Mtb e)
were suspended in 1 ml of PBS and stored at −20°C
until their use.
PMN purification and culture
PMN were isolated from heparinized venous blood from
healthy donors by Ficoll-Hypaque gradient centrifugation
for 40 min. at 350 g and 4°C [29] followed by 20 min. sedi-
mentation in 3% dextran (Sigma). The PMN-rich super-
natant was collected and residual red blood cells were
removed by hypotonic lysis. The cells were washed imme-
diately and suspended at 3 × 106 cells/ml in RPMI-1640
medium (Gibco, NY, USA) supplemented with 1% heat-
inactivated Fetal Calf Serum (FCS) (Gibco) and 50 μg/ml
gentamycin (complete media, CM). The viability was con-
sistently >95% as determined by trypan blue dye exclusion.
The purity of the PMN preparation was up to 95% as
assessed by morphological examination by staining with
Wright-Giemsa and by FACS light scatter pattern. Cul-
tures were performed by incubating 1 ml of a PMN sus-
pension (3 × 106 cell) in Falcon 2063 tubes stimulated at
different Mtb:PMN ratios as indicated (1:2; 2:1; 5:1 to in-
duce cell signaling, 10:1 to see phagocytosis).
Flow cytometric analysis of cells surface phenotype
Cell surface expression of TLR2 and dectin-1 in recently
isolated or 30, 60 and 180 min-cultured PMN was evalu-
ated by direct immunofluorescence using saturating
concentrations of monoclonal mouse antihuman TLR2-
PE- and dectin-1-FITC-conjugated antibodies. Briefly, 5 ×
105 cells were incubated with the antibody for 20 min on
ice, and, after 20-min incubation on ice in the dark, cells
were washed and fixed in 500 μl of 1% paraformaldehyde.
Thereafter, 10,000 events were collected in linear mode
for forward scatter (FSC) and side scatter (SSC), and log
amplification for FL-1 and FL-2, using a FACScan
(Becton-Dickinson Immunocytometry Systems, San Jose,
CA). Analysis was performed using the FACS express soft-
ware (De Novo Software) and isotype matched controls
were used to determine auto-fluorescence and nonspecific
staining. Results were shown as percentages of positive
cells and as mean fluorescence intensity (MFI).
For intracellular staining of cytoplasmic proteins, PMN
were permeated by using a Fix and Perm kit (Caltag,
Burlingame, CA, USA). Briefly, to detect the phosphory-
lated form of p38, 3 × 106 PMN were incubated with
different Mtb strains at 1:2 Mtb:PMN ratio for 30 min.,
and thereafter cells were washed and resuspended
in 100 μL solution A (fixation) for 15 min at room
temperature. After washing with PBS containing 1% Na
azide and 5% FCS, cells were resuspended in solution B
(permeabilization) and mouse antihuman p-p38 IgM anti-
p-p38-FITC revealed with rabbit anti-mouse-IgG-FITC
antibodies. To detect the phosphorylated form of Syk,
PMNs were incubated with different Mtb strains at 1:2
Mtb:PMN ratio for 30 min., in the presence of ortovana-
date in order to avoid phosphatases activation. After
washing with PBS containing 1% Na azide and 5% FCS,
cells were suspended in solution B (permeabilization)
and mouse antihuman anti-p-Syk revealed with donkey
anti-mouse-IgG-FITC antibodies. After 20-min incuba-
tion on ice in the dark, cells were washed, resuspended
in isoflow and acquired in a flow cytometry and ana-
lyzed as previously described.
Oxidative Burst Assay
Intracellular ROS were measured by 123Dihydrorhoda-
mine assay (DHR). DHR was dissolved in DMSO (Sigma)
at 20 μg/ml and stored in aliquots at −70°C until used.
Briefly, 5 × 105 PMN were incubated with 100 μl DHR
(5 μg/ml) for 15 min at 37°C and afterward, Mtb (1 × 106
bacteria/ml) were added to the culture at 1:2 Mtb:PMN
ratio for additional 90 min. When indicated, PMN were
pre-incubated with the free glucan laminarin (10 μg/mL)
[30] or with anti-dectin-1 or anti-TLR2 blocking anti-
bodies. Alternatively, the oxidase inhibitor, DPI (0.1 mM),
cytochalasin D (1 μg/mL) as well as the inhibitors of Syk
(piceatannol, 15 mM) and p38 (SB20358, 20 μM) where
used before Mtb challenge. Afterward PMN were washed,
suspended in isoflow and thereafter, 10,000 events were
collected in linear mode FSC and SSC and log amplifica-
tion for FL-1, in a flow cytometer as mentioned above.
When indicated, ROS production was also induced by
DHR-labeled Mtb (DHRMtb). Briefly, Mtb were incubated
with 5 μg/ml DHR for 30 min at 37°C followed by an ex-
tensive washing to remove free DHR and suspended in
RPMI 1640 plus 10% FCS. Thereafter, 5 × 105 PMN were
incubated with DHRMtb strains at a 10:1 ratio for 90 min
at 37°C, washed and centrifuged at 100 g evaluated imme-
diately in a flow cytometer as previously described.
Detection of Apoptosis Using Annexin-FITC
The percentage of apoptotic PMN was assessed based
on the Annexin V-FITC (Sigma) protein-binding assay.
Briefly, 5 μL of Annexin V-FITC (10 μg/mL) and 5 μL of
propidium iodide (PI) (250 mg/mL) (Sigma) were added
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to 1.2 × 106 cells in 500 μL of binding buffer and incu-
bated for 15 min at room temperature in the dark.
When indicated, PMN were pre-incubated with the free
glucan laminarin or with anti-dectin or anti-TLR2 block-
ing antibodies. Alternatively, the oxidase inhibitor, DPI,
as well as Syk or p38 inhibitors, piceatannol and SB20358
(20 μM) respectively, where used before Mtb challenge.
Cells were washed, resuspended in binding buffer ac-
quired in a flow cytometry, as previously described [24].
AV-/PI- cell population was regarded as alive, AV+/PI-
was considered as an early apoptotic population, and the
AV+/PI + population represented late stage apoptotic
cells. The sum of the last two populations were consid-
ered, and expressed in the results. Inhibitors used in these
experiments did not affect cell viability [24].
Phagocytosis assay
Phagocytosis of Mtb was evaluated by the method de-
scribed by Busseto et al. [31]. Briefly, 3 × 106/ml PMN
were suspended in media with 10% FCS and incubated
in a shaking water bath with opsonized or unopsonized
FITC-labeled Mtb strains for 2 hr at 37°C at a 10:1 ratio
Mtb:PMN. To stop phagocytosis, aliquots of the incuba-
tion mixtures were withdrawn within an equal volume
of Trypan Blue (250 μg/ml) dissolved in ice-cold citrate
buffer (0.1 M, pH 4.0). After 1-min incubation in ice, the
samples were analyzed by flow cytometry. Each sample
was collected for 30 seconds at the slowest flow rate to
minimize the coincidental appearance of free bacteria
and PMN in the laser beam. Opsonization of Mtb was
performed by employing sera from PPD- individuals in
order to avoid the effect mediated by specific antibodies.
When indicated, bacteria where enzimatically treated to
eliminate α-glucans from capsule, as described above.
To evaluate CD11b-mediated phagocytosis, cells were pre-
viously incubated with non relevant IgG1 or with anti-
CD11b blocking antibodies, for 30 min at 37°C before
incubation with Mtb strains. The data were then analyzed
by using CellQuest software from Becton Dickinson. The
mean number of ingested bacteria per PMN was assessed
(i.e., both attached and internalized particles).
IL-8 detection in PMN
Enzyme-linked immunosorbent assays (ELISA) were per-
formed to evaluate IL-8 secretion by PMN in response
to Mtb strains. To that, supernatants from 18 hr-cultured
PMN with different stimuli, were analyzed for cytokine
content using sandwich ELISA (BD Pharmingen) per-
formed as recommended by the manufacturers.
Lipid rafts detection
Flow cytometry
The formation of lipid rafts was determined by the in-
creased expression of the molecule GM1 in the membrane
of PMN, which binds B subunit of cholera toxin conju-
gated with FITC (CTB). For this, 5 × 105 PMN were incu-
bated in RPMI 1640 10% FBS against different clinical
strains at 2:1 Mtb:PMN ratio, for 30, 60 or 120 min. at
37°C and 5% CO2. Then the cells were washed with PBS
and labeled with CTB (5 μg/ml) for 30 min on ice.
When indicated PMN were treated with DPI to inhibit
ROS production previous to Mtb stimulation, or were
stimulated with Mtb subjected to an enzymatic treatment
to eliminate α-glucans from the cell wall. Finally the cells
were washed with PBS, suspended in isoflow and immedi-
ately detected by flow cytometry broadcast FL-1 channel.
Confocal microscopy
After cultured and incubated with CTB, the PMN were
labeled with Propidium (250 ug/ml) to visualize the nu-
cleus, fixed in a solution of 4% PFA and centrifuged.
The formation of lipid rafts was determined by the pres-
ence of clusters of CTB expression by confocal micros-
copy (Olympus) and was analyzed using the program
FV10-ASW 1.7 Viewer.
Statistics
The statistical analysis of the data was performed using
one-way ANOVA followed by Tukey’s multiple compari-
son tests to compare more than two groups followed by
Wilcoxon test to compare two groups. The significance
adopted was p < 0.05. The graphical representation of the
values is given by mean ± SEM.
Results
Dectin-1 and TLR2 participate in Mtb-induced ROS
generation and apoptosis in PMN
Clinical strains Ra and M were chosen because of the
disparity in their ability to induce apoptosis and ROS
production in human PMN that were not due to drug
resistance [28]. As it is shown in Figure 1A and B, whereas
strain M was unable to induce ROS or apoptosis in PMN,
Ra induced high level of ROS in a dose dependent manner,
which correlated with apoptosis rate (Figure 1C). The fact
that ROS is induced at a low ratio of non-opsonized Mtb
to PMN (1:2), would be important during the early phase
of infection when serum opsonins are limited. Therefore
we choose the lower ratio in which differences in ROS and
apoptosis between strains were significant.
Given that TLR2 has been shown to be involved in
apoptosis induced by H37Rv in PMN [25] and in turn it
cooperates with dectin-1 in the recognition of non viru-
lent mycobacteria such as M. smegmatis in MØ [26], we
studied the implication of TLR2 and dectin-1 in the gen-
eration of ROS induced by clinical isolates. We found
that Ra-induced ROS production was significantly re-
duced by blocking dectin-1 with specific antibodies or
with laminarin, a soluble β-glucan. Notably, blockade of
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TLR2 reduced the level of ROS to baseline, suggesting
cooperative participation with dectin-1 to activate sig-
naling (Figure 2A). As previously reported, the CD11b
was not involved in the generation of ROS by Mtb [32],
since CD11b blocking did not affect ROS production.
Figure 2B reflects a clear dependence between Ra-
induced apoptosis and ROS production that has been
evidenced by the effect of NADPH oxidase inhibitor
diphenyleneiodium (DPI). In clear contrast, none of the
treatments modified the effect of the strain M on apop-
tosis or ROS production.
To rule out that the increased production of ROS was
due to an up-regulation of dectin-1 and/or TLR2 on
PMN surface, the expression of these receptors was
measured by flow cytometry on freshly isolated or cul-
tured PMN with media alone or exposed to Mtb strains
for 30, 60 or 180 min. As is shown in Figure 2C and D,
neither strains Ra nor M induced a change on TLR2 or
dectin-1 expression in PMN, so we can discard a recep-
tor modulation as a cause of the increased ROS produc-
tion induced by Ra.
Mtb-induced ROS production involves p38 MAPK and Syk
activation
Considering that dectin-1 and TLR2 participate in ROS
production induced by Ra, we evaluated the role of Syk
and p38 signaling cascade downstream of these recep-
tors. As shown in Figure 3A, the Ra-induced ROS pro-
duction was remarkably reduced by the specific inhibitor
of Syk activation, piceatannol (Pic). Moreover, SB203580,
the specific inhibitor of p38 MAPK activation also re-
duced ROS to baseline, suggesting that both molecules
may participate in ROS generation.
Then, in order to assess whether the observed differ-
ences in the ability to induce ROS by strains Ra and M
could be due to a differential capacity to activate p38
MAPK and Syk, the expression of their activated form in
the cytoplasm was examined. As shown in Figure 3B, Ra
strain significantly induced activation of p38 MAPK and
Syk, whereas M was not able to induce activation over
baseline. Furthermore, Ra-induced Syk activation was
dependent on dectin-1 receptor because it was signifi-
cantly inhibited by the blockade of dectin-1.
Mtb strains differentially induce GM1 expression in PMN
Lipid rafts are membrane microdomains enriched in
cholesterol and glycosphingolipids that have been impli-
cated in signal transduction and immune responses
[33]. Components of the NADPH oxidase do indeed
localize in lipid microdomains indicating that lipid rafts
mediate the efficiency of oxidase coupling to a receptor
in PMN membrane [34]. The role of lipid rafts in Mtb-
Figure 1 ROS induced by strain Ra is dose dependent and correlates with apoptosis. (A) PMN were pretreated with DHR and incubated
with different relations of Mtb:PMN (1:2, 2:1 and 5:1). Thereafter, the emission of oxidized DHR was evaluated by flow cytometry as a measure of
oxidative burst. The results are expressed as mean ± SE (n = 16); control (−−) vs. all Mtb:PMN ratios ***p < 0.001; 1:2 vs. 2:1; 1:2: vs. 5:1 and 2:1 vs.
5:1 Mtb:PMN ratio: #p < 0.05 (B) Apoptosis was measured in 18-hr cultured PMN with or without the presence of clinical strains as described in
(A). Results are expressed as the percentage of AV-FITC positive cells (% PMN AV + ± SE) (n = 16); control (−−) vs. all Mtb:PMN ratios: **p < 0.001;
1:2 vs. 2:1; 1:2: vs. 5:1 and 2:1 vs. 5:1 Mtb:PMN ratio: #p < 0.05; C) correlation between ROS generation and apoptosis of PMN (p < 0.0001,
r2: 0.9826).
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induced ROS production was assessed by employing
Methyl-β-cyclodextrin (MβC), which disrupts lipid rafts
by removing cholesterol from membranes. As can be
seen in Figure 4A, MβC caused a significant decrease in
Ra-induced ROS production, indicating that a proper
coalescence of lipid rafts is a requisite in ROS gener-
ation induced by this strain.
Therefore, expression of the GM1 molecule was deter-
mined in the membrane of PMN, through binding of
cholera toxin B subunit conjugated with FITC (CTB-
FITC) [35]. Ratio 2:1 Mtb:PMN was used for CTB meas-
ure, to see clearly the differences in the image, whereas
M did not induce ROS (see Figure 1A). A uniform distri-
bution of GM1 can be observed in untreated PMN or in
PMN treated with strain M, while GM1 was clustered into
patches in Ra-stimulated PMN (Figure 4B). Thereafter,
GM1 expression was measured by flow cytometry, consid-
ering that higher GM1 clustering is shown as higher fluor-
escence intensity [36]. Noticeably, strain Ra induced an
increase in GM1 expression that reached a peak at 60 min-
culture, while it was constant over time in the control
without stimuli or in M-stimulated PMN (Figure 4C).
Mtb-induced GM1 expression in PMN is dependent on TLR2
It has been described that TLR2 agonists of Mtb induce
coalescence of lipid rafts, translocation of TLR2 to lipid
rafts, and ROS production [37]. As showed above, TLR2
participates in Ra-induced ROS production, thus we in-
vestigated the role of TLR2 in the up-regulation of GM1
expression induced by our strains. As shown in Figure 4D,
whereas laminarin had not effect, the blockage of TLR2
abrogated the increase of GM1 expression suggesting
that only TLR2 and not dectin-1 is involved in lipid raft
coalescence.
On the other hand, pre-treatment with DPI hampered
the GM1 expression in PMN membrane, suggesting that
ROS are necessary for the aggregation of raft domains
(Figure 4D). Therefore, it seems that while lipid rafts par-
ticipate in ROS production induced by strain Ra, in turn
ROS is necessary for lipid raft coalescence.
Phagocytosis of nonopsonized bacteria involves α-glucans
on cell wall and is strain dependent
We have previously reported a more efficient entry of Ra
into PMN compared to strain M [28]. Therefore, in order
Figure 2 dectin-1 and TLR2 participate in Mtb-induced ROS and apoptosis in PMN. A) PMN were pretreated with DHR and incubated with
or without neutralizing anti-TLR2, anti-dectin-1, anti-CD11b, irrelevant IgG antibodies or the β-glucan laminarin, and then stimulated with Ra or M
for 90 min at 1:2 ratio Mtb:PMN. Thereafter, the emission of oxidized DHR was evaluated by flow cytometry. Results are expressed as mean ± SE
(n = 12); control (−−) vs. Ra, Ra + IgG and Ra + anti-CD11b: ***p < 0.001 (B) Apoptosis was measured in 18-hr cultured PMN with or without
clinical strains, under the same conditions described in (A) and evaluated by flow cytometry. Results are expressed as the percentage of AV-FITC
positive cells (% PMN AV + ± SE) (n = 20); control (−−) vs. Ra, Ra + IgG and Ra + anti-CD11b: ***p < 0.001. (C) TLR2 and (D) dectin-1 expression
was measured at the surface of the PMN after 30, 60 or 180 minutes culture, in the presence of Mtb (1:2 Mtb:PMN ratio) (n = 16) and evaluated
by flow cytometry.
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to evaluate the nature of these differences, a phagocytosis
assay was performed with both non-opsonized and opson-
ized Mtb using a high ratio Mtb:PMN (10:1) due to a limi-
tation of the assay, just to see fluorochrome emission. As
shown in Figure 5A, bacterial opsonization improves
phagocytosis of both strains M and Ra, which was pre-
vented by exposure of serum to 56°C for 30 minutes (de-
naturing of complement factors, serum-ø) suggesting that
phagocytosis mediated by complement factors is similar in
both strains, whereas when non-opsonized, M was less ef-
ficient than Ra to enter PMN.
Among a variety of Mtb receptors in the membrane of
PMN, CD11b is one of the main receptor of phagocytosis
which binds complement factor C3bi, as well as non-
opsonized bacteria at a different site from C3bi binding
site [38]. As shown in Figure 5B, complement-mediated
phagocytosis of both strains was reduced by CD11b block-
ade whereas it only affected the non-opsonic phagocytosis
of Ra. Although a differential binding to CD11b was not
evaluated, these results suggest that differences between
strains arise in the lectin like domain. However, even with
the blockade, phagocytosis of unopsonized M remained
significantly lower than Ra so that we cannot rule out dif-
ferences at the binding to other receptors.
It has been described that Mtb interacts with CD11b,
through capsular polysaccharides, which may be depen-
dent on the strain. Moreover, the binding range of the
CD11b lectin site can be extended to include a
glycogen-like α-1,4-glucan from the Mtb capsule indi-
cating that outer capsular polysaccharides mediate the
non-opsonic binding to CD11b [39]. In order to evalu-
ate whether α-glucan of the capsule participates in the
entrance of Mtb, clinical strains were treated with 1,4-α-
glycosidase to remove α-glucans, and the phagocytosis of
opsonized and non-opsonized bacteria was compared
with intact bacteria. As can be seen in Figure 5C,
elimination of α-glucans dramatically reduced phagocyt-
osis of non-opsonized bacteria whereas complement-
mediated phagocytosis was not significantly altered,
suggesting that capsular polysaccharides participate in
the phagocytosis of non-opsonized Mtb and are strain
dependent.
Figure 3 Role of p-38-MAPK and Syk in Mtb-induced ROS production by PMN. (A) PMN were pretreated with DHR and incubated with
specific p38 MAPK and Syk inhibitors, SB203580 and piceatannol, respectively (SB and Pic) for 30 min. previous to bacteria challenge (1:2 Mtb:PMN
ratio for 90 minutes). Thereafter, the emission of oxidized DHR was evaluated by flow cytometry. Results are expressed as mean ± SE (n = 20); Ra
alone vs. all conditions: ***p < 0.001. (B) Percentage of cells that express the activated form of cytoplasmic p38 MAPK and Syk. PMN were
incubated with Ra or M strains with neutralizing anti-dectin-1 or corresponding isotype. A representative experiment of 10 done is depicted.
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ROS production in PMN involves phagocytosis and
α-glucans on Mtb
In order to evaluate whether ROS production in PMN
was dependent on bacterial phagocytosis, PMN were in-
cubated with 10 μM of cytochalasin D (CytD), an inhibi-
tor of actin polymerization, before the addition of Mtb.
As can be seen in Figure 6A and B (1:2 and 10:1 Mtb:
PMN ratio, respectively), the induction of ROS was
significantly reduced on CytD-treated PMN and closely
resembled the non-stimulated control, suggesting that
Ra-induced ROS production requires the phagocytosis
of the bacteria. Notably, when ROS was induced by
DHR-labeled Mtb (oxidized DHR exclusively comes
from ingested bacteria, DHRMtb), CD11b blockade did not
affect ROS production, and more over, opsonized bacteria
showed a reduced capacity to induce ROS (Figure 6C).
These results together support the motion that ROS
production is mainly induced by phagocytosis of non-
opsonized bacteria through a receptor different from
CD11b. Considering that the α-glucans present in the
bacteria cell wall participate in the phagocytosis of Mtb,
we evaluated the role of α-glucans in ROS production.
Figure 6D shows that removing α-glucans by enzymatic
digestion with 1,4-α-glycosidase provoked a reduction in
ROS to basal levels, suggesting that α-glucans participate
in the oxidative process. Accordingly, the elimination of
α-glucans abolished the ability to induce PMN apoptosis
(Figure 6E).
α-glucans did not participate in GM1 expression or IL-8
secretion by PMN
Given that ROS production depends on α-glucans in the
bacteria, but also depends on lipid rafts coalescence, we
wondered if the α-glucans would be participating in the
coalescence of lipid rafts. Next, we evaluated the ability
to induce expression of GM1 by enzymatically treated
bacteria and we found that the cell wall structure must
be intact, because heated Mtb lost its ability to induce
expression of GM1, however, removal the α-glucans had
no effect, indicating that this component of the capsule
is not involved in the coalescence of lipid raft, despite
being involved in the production of ROS (Figure 7A).
Moreover, clinical strains differentially induce IL-8 secre-
tion by PMN as determined in the supernatant of 18-hour
culture of PMN stimulated by Ra and M. The TLR2 agon-
ist, Pam3Cys, was also employed as stimulus because IL-8
production is mediated by TLR in PMN [40]. As shown in
Figure 7B, the secretion of IL-8 induced by strain Ra
reached comparable levels to Pam3Cys, while strain M in-
duced a lower effect, even if significant. In addition, the
Figure 4 Ra strain induces GM1 expression in PMN surface. (A) PMN treated with DHR were incubated with the lipid rafts inhibitor MβC,
before challenge with 1:2 Mtb:PMN. Thereafter, the emission of oxidized DHR was evaluated by flow cytometry. Results are expressed as mean ± SE
(n = 12); Ra vs. control (−−), Ra + MβC or M: ***p < 0.001 (B) PMN were cultured with bacteria and incubated with CTB-FITC and thereafter, lipid rafts
were determined by the presence of clusters of GM1 expression by confocal microscopy. Propidium yodide (250 μg/ml) was used to visualize the
nucleus. One of 4 experiments is depicted (C) PMN were cultured with a 2:1 Mtb:PMN ratio for 30, 60 o 120 min. Thereafter, cells were labeled with
CTB-FITC (5 μg/ml) and fluorescence evaluated by flow cytometry. Results are expressed as mean ± SE (n = 7); control (−−) vs. Ra: *p < 0.05. (D) PMN
were incubated with the ROS inhibitor DPI, MβC, laminarin, anti-TLR2 or irrelevant antibody for 30 min. at 37°C before challenge with Ra or M at 2:1
Mtb:PMN ratio. Thereafter, cells were labeled as described in (C). Results are expressed as mean ± SE (n = 7); control (−−) vs. Ra, laminarin or irrelevant:
*p < 0.05.
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removal of the α-glucans did not alter Mtb-induced IL-8
secretion, indicating that α-glucans do not mediate the
production of this cytokine. Besides, while heated bacteria
abolish lipid raft coalescence and IL8 secretion, as this
treatment alter recognition of TLR2 ligands, the enzyme
treatment did not affect these surface structures.
Considering that M did not induce GM1 expression,
we wondered if their inability to induce ROS could be
due to a failure in the induction of lipid rafts, in the inter-
action through the α-glucans or both. To assess this,
PMN were first incubated with enzymatically-treated Ra
(Ra e), which retains the ability to induce lipid rafts but
loses the ability to generate ROS, and then M was added.
In the same manner, other experiments were carried out
employing the TLR2 agonist, Pam3Cys. The results show
that even in these conditions, M was unable to induce
ROS (Figure 7C) suggesting that both events are compro-
mised: TLR2-dependent lipid raft coalescence and the
presence of α-glucans in the cell wall. Finally, signaling via
Syk might involve α-glucans, given that their removal sig-
nificantly reduced Syk activation (Figure 7D).
Discussion
The virulence of a certain Mtb genotype can be defined
as its ability to cause active disease in humans. Thus, the
level of clustering, revealed by molecular genotyping tech-
niques, can be regarded as a measurable parameter of
virulence [41]. Herein, we focused on two MDR-clinical
strains representative of two families that nowadays show
prevalent geographic niches [17]. While the genomic dif-
ferences between these genotypes may be slight, they may
lead to remarkable phenotypic differences among strains
that influence epidemiologic and clinical outcomes of the
disease [42].
Although mutations that confer drug resistance can
imply a fitness cost, some MDR Mtb genotypes are able
to overcome this disadvantage and are as virulent as fully
drug-sensitive genotypes [43]. Unlike other pathogens,
Mtb lacks typical virulence factors such as toxins; there-
fore, epidemiologic fitness of a strain can be influenced by
a range of factors, for instance, the genetic background of
host and pathogen, host–pathogen interactions, and the
environment [44,45]. Thus, the accumulation of drug
Figure 5 Non-opsonic phagocytosis is strain dependent and involves α-glucans on Mtb. (A) PMN were incubated with FITC labeled-Mtb
opsonized (serum) with intact or heated (ø) PPD negative serum (10:1 Mtb:PMN). Results are expressed as% of PMN that phagocytosed Mtb
(% PMN Mtb FITC ± SE); Ra vs. Ra + serum: *p < 0.05; M vs. M + serum: ***p < 0.001; Ra vs. M: φp < 0.05; R + serum vs. R + serum-ø: ##p < 0.01;
M + serum vs. M + serum-ø: ##p < 0.01 (B) PMN were incubated with blocking anti-CD11b antibodies prior to incubation with FITC-Mtb opsonized
or not. Results are expressed as% of PMN that phagocytosed Mtb (% PMN Mtb FITC ± SE); Ra vs. Ra + serum: *p < 0.05; M vs. M + serum:
***p < 0.001; Ra vs. Ra + aCD11b: #p < 0.05; Ra + serum vs. Ra + serum + aCD11b: ##p < 0.05; M + serum vs. M + serum + aCD11b: ##p < 0.05; Ra,
Ra + aCD11b and Ra + serum + aCD11b vs. M, M + aCD11b and M + serum + aCD11b: φp < 0.02 (C) PMN were incubated with opsonized or
non-opsonized FITC-Mtb that were treated (Mtb e) or not with α-glycosidase. Results are expressed as% of PMN that phagocytosed Mtb (% PMN
Mtb FITC ± SE); Ra vs. Ra + serum: *p < 0.05; M vs. M + serum: ***p < 0.001; Ra vs. Ra e and M vs. M e: ##p < 0.01; Ra, Ra + serum and Ra e + serum
vs. M, M e and M e + serum: φp < 0.05.
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resistance-conferring mutations would be expected to re-
duce the epidemiological fitness of the strain M, but they
have prevailed for over 15 years. Compensatory evolution
restoring in vivo fitness, as well as social and behavior fac-
tors, may have played a role in the epidemiological persist-
ence of strain M.
The intracellular replication of the pathogen and its
spread from the lungs to other sites occur before the de-
velopment of adaptive immune responses. Thus, innate
immune mechanisms play an important role during the
early stages of Mtb infection. In this context, PMN are
the first cells to arrive at the site of infection and play a
significant protective role in the elimination of invading
pathogens through ROS production [20] or by limiting
inflammation by succumbing to apoptosis [27]. There-
fore, inhibition of ROS would increase not only the sur-
vival of the bacteria but also of PMN, which represents a
remarkable Mtb trick to establish an abiding protected
niche where bacteria can avoid elimination by the im-
mune system [46,47].
We have previously demonstrated that clinical strains
belonging to the LAM family have a strong ability to in-
duce PMN apoptosis that depends on their capability to
generate ROS production. However, clinical strains from
Haarlem family induce less PMN apoptosis and ROS
and particularly, strain M is unable to induce apoptosis
due to a failure to stimulate ROS production and the in-
duction of anti-apoptotic pathways [28].
Herein, we show that ROS generation and apoptosis
induced by the MDR strain LAM Ra are dependent on
dectin-1 and TLR2 receptors with the subsequent activa-
tion of p38 MAPK and Syk. In this context, the involve-
ment of TLR2 and p38 MAPK pathway has also been
described in ROS production induced with PPD in MØ
[12]. Furthermore, these differences could not be ascribed
to a modulation of TLR2 or dectin-1 expression, which is
in contrast with that observed in non-phagocytic cells
[48]. Moreover, Ra-induced Syk activation involves dectin-
1 receptor, as described for zymosan [14,15], and M.
abscessus [37]. Moreover, TLR2/dectin-1 cooperation has
been described to induce the production of ROS, together
with the rapid and sustained phosphorylation of p38
MAPK and Syk [37], in Mo and PMN [26,49].
It has been recognized that a variety of pathogens
interact with plasma membrane lipid rafts which are in-
volved in the attachment, cell entry, and intracellular
survival of several microorganisms such as Brucella suis
[50], Chlamydia trachomatis [51], and M. bovis [52]. In
Figure 6 α-glucans and non-opsonized phagocytosis are involved in ROS production. (A) PMN were pretreated with DHR and incubated
with 1:2 Mtb:PMN ratio for 90 min (black line), pre-incubated with cytochalasin D (gray line) or, PMN without treatment (filled gray). Alternatively,
PMN were pre-treated with anti-CD11b, second histogram (gray line). Representative out of 6 experiments are depicted (B) PMN pretreated with
DHR were incubated with cytochalasin D or DPI prior to incubation with 10:1 Mtb:PMN ratio for 90 min. Results are expressed as a mean ± SE
(n = 20); control (−−) vs. Ra ***p < 0.001; control (−−) vs. M *p < 0.05; Ra vs. M φp < 0.01; Ra vs. Ra + cytD or Ra + DPI: ##p < 0.01; M vs. M + cytD
or M + DPI ##p < 0.01 (C) DHR-labeled Mtb (DHRMtb) were incubated with 5 × 105 PMN at a 10:1 ratio for 90 min. Results are expressed as a
mean ± SE (n = 20). Ra vs. Ra + serum ##p < 0.01; M vs. M + serum ##p < 0.01; Ra vs. M φp < 0.01 (D) PMN were pretreated with DHR and
incubated with 1:2 Mtb:PMN ratio for 90 min. The α-glucans of clinical strains were eliminated (Ra e, M e) or not (Ra, M) as described in Methods.
Results are expressed as a mean ± SE (n = 15); control (−−) vs. Ra ***p < 0.001; Ra vs. Ra e: ###p < 0.001. In all cases emission of oxidized DHR
was evaluated by flow cytometry (E) Apoptosis was measured in 18-hr cultured PMN in the same conditions described in (A). Results are
expressed as percentage of AV-FITC positive cells (% PMN AV + ± SE); control (−−) vs. Ra **p < 0.01; Ra vs. Ra e: ###p < 0.001.
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addition, components of the NADPH oxidase localize in
membrane lipid rafts which are signaling platforms
enriched in cholesterol [53], which mediates the effi-
ciency of oxidase coupling to the receptor in PMN. In
this context, we demonstrated that lipid rafts participate
in Ra-induced ROS production and in this way rafts for-
mation depends on TLR2. As lipid rafts also depended
on ROS, we propose that some level of ROS generated
by TLR2 signaling is necessary to induce the lipid rafts
coalescence. Accordingly, a translocation of TLR2 to
lipid rafts associated with ROS production has been
demonstrated with Mtb 19 kDa lipoprotein [37].
Herein, we show that phagocytosis of Mtb is necessary
to trigger ROS production. In addition, complement-
mediated phagocytosis was similar in both strains, whereas
M was less efficient than Ra when not opsonized [28]. The
carboxyl-terminal end of the extracellular portion of the
CD11b α-chain contains a lectin like C-domain involved
in binding to oligosaccharides [38] including binding to
mycobacterial polysaccharides [39]. Thus, we considered
CD11b as a receptor which differentially binds these two
strains. However, while the CD11b blockade reduces the
non-opsonic phagocytosis of Ra, M remains significantly
lower (Figure 5B) suggesting that another receptor may be
involved. Moreover, when oxidized DHR comes from
ingested bacteria, the blockade of CD11b does not affect
ROS production, whereas opsonized bacteria show a re-
duced capability to induce ROS (Figure 6C). These results
support the notion that ROS production is mainly induced
by phagocytosis of non-opsonized bacteria through a
different receptor from CD11b. In line with this, the en-
zymatic digestion of α-glucans prevents phagocytosis of
non-opsonized bacteria, suggesting a role for α-glucans in
phagocytosis, Syk activation and ROS production.
Little is known about how dectin-1-dependent inflamma-
tory signaling is regulated during mycobacterial infection.
The involvement of dectin-1 as a receptor to α-glucans
is unlikely because it is associated with the recognition
of β-glucans [13]. However, it has also been implicated
in antimycobacterial immunity, though the ligand/s has
not yet been identified [26,37,54]. Furthermore, dectin-1
also differentially recognizes glucans based on structural
Figure 7 α-glucans are not involved in the expression of GM1, or in the secretion of IL-8. (A) PMN were cultured with Ra and M strains,
enzimatically treated Mtb (Ra e, M e) or heat killed Mtb (ht Ra, ht M), in a 2:1 Mtb:PMN ratio. Thereafter cells were labeled with CTB-FITC and
fluorescence evaluated by flow cytometry. Results are expressed as a mean ± SE (n = 12); control (−−) vs. Ra and Ra e: *p < 0.05; Ra and Ra e vs.
ht Ra ##p < 0.01; M and M e vs. ht M: ##p < 0.01. (B) PMN were cultured for 18 hr at 1:2 Mtb:PMN ratio. Pam3Cys was used as control. IL-8 was
measured in supernatant employing ELISA kits as described in Methods. Results are expressed as mean ± SE (n = 10); control (−−) vs. Ra, Ra e and
Pam3Cys: **p < 0.01, control (−−) vs. M and M e: *p < 0.05; Ra and Ra e vs. ht Ra #p < 0.05; M and M e vs. ht M: #p < 0.05. (C) PMN incubated with
DHR were cultured with enzimatically treated Ra (Ra e) or Pam3Cys and thereafter cells were challenged with M for additional 60 min (1:2 Mtb:PMN
ratio). Emission of oxidized DHR was evaluated by flow cytometry. Results are expressed as a mean ± SE (n = 12); control vs. Ra or Pam3Cys + Ra:
***p < 0.001; Ra or Pam3Cys + Ra vs. Ra e, M, M e, Ra e + M or Pam3Cys + M: #p < 0.05. (D) Percentage of cells that express the activated form of Syk
in PMN incubated with Ra, M or enzimatically treated Ra (Ra e) clinical strains. One representative experiment of 10 is depicted.
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factors that include polymer length and side-chain
branching [55,56] making it highly specific for glucans
that have a (1→ 3)-β-D-glucopyranosyl backbone. Sugar
recognition through C-type lectins has been found to be
altered depending on the degree of saccharide acylation
[57]. Therefore, the differences in the production of ROS
between Ra and M strains may be due to its ability to
enter the PMN and signal through Syk.
Conclusions
In the present study, we investigated the mechanisms
governing Mtb-induced ROS in PMN. Our results dem-
onstrate that ROS is generated during the phagocytosis
of non-opsonized mycobacteria through α-glucans and
with the participation of dectin-1 and TLR2 involving p38
MAPK and Syk activation. Clinical strain M lacks the
ability to induce ROS because of: 1) a reduced phagocyt-
osis and 2) reduced lipid raft coalescence, a mechanism
that would be beneficial for intracellular Mtb survival.
Confirmation of this hypothesis awaits capsular charac-
terization, which we are currently evaluating.
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